GSK3B and cancer: Several studies reported that some AURKA substrates, including GSK3β and β-catenin, participated in crucial oncogenic signaling (Mou et al., 2021), and AURKA directly phosphorylated GSK3β in cancer cells, which stabilized β-catenin and activated Wnt signaling (Dar et al., 2009).